The Global Human Rabies Vaccines Market was valued at USD 963.53 Million in 2022 and is expected to reach USD 1,391.36 Million by 2030, growing at a CAGR of 4.7% (2023-2030).
The Global Bacterial Vaccines Market was valued at USD 26.97 Billion in 2025 and is expected to reach USD 50.66 Billion by 2033, growing at a CAGR of 8.2% (2026-2033).
The Global Avian Influenza Vaccines Market was valued at USD 124.53 Million in 2021 and is expected to reach USD 196.25 Million by 2029, growing at a CAGR of 5.85% (2022-2029).
The Global Human Rabies Vaccines Market was valued at USD 963.53 Million in 2022 and is expected to reach USD 1,391.36 Million by 2030, growing at a CAGR of 4.7% (2023-2030).
The Global Bacterial Vaccines Market was valued at USD 26.97 Billion in 2025 and is expected to reach USD 50.66 Billion by 2033, growing at a CAGR of 8.2% (2026-2033).
The Global Avian Influenza Vaccines Market was valued at USD 124.53 Million in 2021 and is expected to reach USD 196.25 Million by 2029, growing at a CAGR of 5.85% (2022-2029).
The Global Human Rabies Vaccines Market was valued at USD 963.53 Million in 2022 and is expected to reach USD 1,391.36 Million by 2030, growing at a CAGR of 4.7% (2023-2030).
The Global Personalized Cancer Vaccines Market was valued at USD 234,790.00 Million in 2022 and is expected to reach USD 371,404.60 Million by 2030, growing at a CAGR of 5.9% (2023-2030).
The Global Avian Influenza Vaccines Market was valued at USD 124.53 Million in 2021 and is expected to reach USD 196.25 Million by 2029, growing at a CAGR of 5.85% (2022-2029).
The Global Bacterial Vaccines Market was valued at USD 19.68 Billion in 2021 and is expected to reach USD 36.97 Billion by 2029, growing at a CAGR of 8.2% (2022-2029).